EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The peripheral PI3K/AKT/MLC signalling pathway alleviates myofascial pain in rats by inhibiting abnormal contraction at myofascial trigger points

Mingyang Zhang iD, Yuchang Zhu, Feihong Jin, Yu Liu, Luhua Yin iD

Molecular Pain · 2025

DOI: 10.1177/17448069251376205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pain, 2025. Verfasst von Mingyang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Signal Transduction, Myofascial Pain Syndromes, Muscle Contraction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Shandong Province Traditional Chinese Medicine Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myofascial trigger points (MTrPs) for abnormal skeletal muscle contraction are the cause of myofascial pain. The G protein-coupled receptor family and tyrosine kinase receptor family regulate the contraction of vascular smooth muscle through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway. Phosphorylated myosin light chain (p-MLC) is associated with skeletal muscle contraction. The aim of the current study was to explore the effect and mechanism of the PI3K/AKT/MLC signalling pathway on myofascial pain in rats.

Methods

A rat model of myofascial pain was established by a blunt strike to the gastrocnemius muscle combined with centrifugal exercise for 8 weeks, followed by recovery for 4 weeks. Different concentrations of the PI3K inhibitor LY294002 (0.01, 0.1, or 1 mg/ml) were subsequently injected into the MTrPs of rats with myofascial pain to observe the effects on the mechanical tenderness threshold at the MTrPs.

Results

LY294002 (0.1 mg/ml) inhibited myofascial pain at 0.5, 1 and 2 h after injection, and LY294002 (1 mg/ml) inhibited myofascial pain at 0.5, 1, 2 and 4 h after injection. The expression of PI3K increased on the enlarged muscle fibre membrane at MTrPs. LY294002 (1 mg/ml) inhibited the expression of PI3K, p-AKT, and p-MLC and the abnormal contraction of muscle fibres at MTrPs and alleviated nerve fibre compression at MTrPs. Moreover, LY294002 inhibited the expression of Fos in the spinal dorsal horn of rats with myofascial pain.

Conclusions

These findings suggested that the increased expression of PI3K/p-AKT/p-MLC was related to myofascial pain in rats and that the PI3K inhibitor LY294002 might alleviate myofascial pain in rats by inhibiting abnormal contraction at MTrPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktSignal TransductionMyofascial Pain SyndromesMuscle ContractionPhosphatidylinositol 3-KinasesMyosin Light ChainsTrigger PointsAnimalsMaleRats, Sprague-DawleyRatsMorpholinesChromonesMuscle, SkeletalPhosphorylation

Stichwörter der Autor:innen

LY294002PI3Kmyofascial pain syndromemyofascial trigger points

Substanzen

Proto-Oncogene Proteins c-akt2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-onePhosphatidylinositol 3-KinasesMorpholinesMyosin Light ChainsChromones

Autor:innen und Institutionen

  • The Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong, China.
  • Department of Anesthesiology, The Affiliated Tengzhou Central People's Hospital of Xuzhou Medical University, Tengzhou, Shandong, China.
  • Department of Anesthesiology, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong, China.
  • Department of Anesthesiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

ORCID-Profile: Mingyang Zhang, Luhua Yin

Förderung

  • the Shandong Province Traditional Chinese Medicine Technology Project

Zitieren

APA

Zhang, M., Zhu, Y., Jin, F., Liu, Y., & Yin, L. (2025). The peripheral PI3K/AKT/MLC signalling pathway alleviates myofascial pain in rats by inhibiting abnormal contraction at myofascial trigger points. Molecular Pain. https://doi.org/10.1177/17448069251376205

Vancouver

Zhang M, Zhu Y, Jin F, Liu Y, Yin L. The peripheral PI3K/AKT/MLC signalling pathway alleviates myofascial pain in rats by inhibiting abnormal contraction at myofascial trigger points. Molecular Pain. 2025. doi:10.1177/17448069251376205

BibTeX
@article{Zhang2025,
  author = {Zhang, Mingyang and Zhu, Yuchang and Jin, Feihong and Liu, Yu and Yin, Luhua},
  title = {The peripheral PI3K/AKT/MLC signalling pathway alleviates myofascial pain in rats by inhibiting abnormal contraction at myofascial trigger points},
  journal = {Molecular Pain},
  year = {2025},
  doi = {10.1177/17448069251376205}
}
Kostenlos starten →